PSRC Abstract Supplement sequestration of doxorubicin. The ability of our platform to be personalized for individual patients may allow us to not only elucidate how the microenvironment affects BC cells, but also how patient specific tissue impacts the effects of various chemotherapeutic agents.
METHODS:
We performed single cell transcriptional profiling to cluster ASCs based on expression of key antifibrotic genes and then used linear discriminant analysis to identify surface markers correlating with these clusters. Dermal fibroblasts were incubated with conditioned media from CD74+, CD74-, or unsorted ASCs. Ten ng of TGF-β1 was then added to stimulate the fibroblasts and assess for procollagen type-1 production. Adult immunocompromised CD-1 nude mice were treated with 30 Gy external beam irradiation to their scalp, delivered as six fractionated doses of 5Gy over a period of 12 days. After a 5-week recovery period, irradiated mice and nonirradiated control mice were grafted with 200ul human lipoaspirate enriched with CD74+, CD74-, or unsorted ASCs. Fat graft retention was monitored radiographically over 8 weeks, at which point the mice were sacrificed and the grafted fat and overlying skin were processed for histology.
RESULTS:
Single cell transcriptional profiling identified multiple surface markers which correlated with expression of antifibrotic genes. Subsequent analysis of bulk transcriptional data revealed CD74+ to identify a subpopulation of ASCs with high expression of the antifibrotic genes HGF, FGF2, and TGF-β3 (*p<0.05). Dermal fibroblasts cultured in CD74+ ASC conditioned media exhibited decreased procollagen type 1 production upon stimulation, compared to fibroblasts cultured in media from CD74-or unsorted ASCs. Grafted fat enriched with CD74+ ASCs was less fibrotic, contained less vacuoles and cysts, and had increased vascularization compared to fat supplemented with CD74-or unsorted ASCs. The CD74+ ASC-enriched fat also exhibited the greatest retention rates. These effects were more apparent in the irradiated setting.
CONCLUSION: CD74+ ASCs are a subpopulation of ASCs with anti-fibrotic qualities, and supplementation of lipoaspirate with CD74+ ASCs can improve graft retention and enhance fat graft quality. These results suggest that fibrotic remodeling in the recipient site may play an important role in the integration and vascularization of the grafted tissue. PURPOSE: Near-infrared spectroscopy (NIRS) monitoring devices are a widely used adjunct to serial physical exams for microsurgical flap monitoring. Currently available two wavelength NIRS devices do not directly measure tissue ischemia but use the relative amount of oxidized hemoglobin to deoxyhemoglobin to calculate blood oxygen saturation (StO2). Although NIRS devices clinically improve early detection of flap compromise, StO2 readings have significant artifactual variation requiring vigilant clinician interpretation to avoid unnecessary flap re-exploration. We have previously reported the performance characteristics of a three wavelength NIRS device designed to detect the oxidation state of cytochrome aa3, which is a direct measure of cellular ischemia. The device lessened StO2 variation using an established ischemia and reperfusion model, but did not adequately reflect cytochrome aa3 oxidation state. The objective of this study was to compare a broadband NIRS device using white light (> 1000 wavelengths) to the standard two wavelength NIRS device (ViOptix Inc, Freemont CA) commonly employed for flap monitoring by measuring StO2 variability during ischemia and reperfusion and corresponding cytochrome aa3 oxidation -a direct measure of cellular ischemia.
METHODS:
The two NIRS devices, ViOptix and the broadband NIRS device, were applied to the hands of human volunteers (n = 20) and a blood pressure cuff was placed around the upper arm to occlude arterial and venous flow, as previously described. Measurements were obtained from both devices at baseline, during induced ischemia, and during reperfusion at 30-second intervals. StO2 variability was measured during ischemia and reperfusion between both devices, as was the correlation of broadband-reported cytochrome aa3 oxidation state to StO2 changes.
RESULTS:
The StO 2 measurements from both devices proportionally decreased during ischemia with similar variability. The broadband device reported cytochrome aa3 changing from an oxidized to reduced state during ischemia, which began even during baseline cuff placement before StO2 decreased. Once the ischemia and reperfusion reporting phases began, cytochrome aa3 oxidation state correlated with StO2 readings from both devices.
CONCLUSIONS:
The ViOptix and broadband NIRS devices performed similarly with regard to ability to measure StO2 as a surrogate marker of tissue ischemia. However, the use of broadband white light wavelength NIRS monitoring also provided the capability of directly measuring cellular ischemia through cytochrome aa3 oxidation state. Interestingly cytochrome aa3 oxidation-reduction state was sensitive even to minor changes in tissue perfusion. Future work will evaluate clinically critical differences in cellular oxidation reporting in a flap model. Critical to the evolution of this ideal bioprosthetic device is the development of a reliable, biologic human-machine interface that facilitates transmission of both efferent motor signals for device control, and afferent somatosensory information. The Composite Regenerative Peripheral Nerve Interface (C-RPNI) is a novel biologic interface that demonstrates promise in this role. The C-RPNI is a surgical construct composed of a transected, mixed peripheral nerve implanted between a composite free graft consisting of de-epithelialized glaborous skin and skeletal muscle. The purpose of the present study was to investigate the viability and bidirectional signal transduction capabilities of the C-RPNI.
METHODS:
C-RPNIs were surgically implanted on the end of transected common peroneal nerves of thirty F344 rats using de-epithelialized dermal grafts harvested from glaborous skin of isogenic donor rat hindpaws and free skeletal muscle grafts from the animal's contralateral limb. Thirty animals underwent endpoint testing at three months (n=15) and at six months (n=15). Electrophysiologic testing was performed to determine both the in vivo efferent and afferent signal transduction capabilities of C-RPNIs following electrical stimulation. C-RPNI constructs were also harvested for histologic evaluation at both three-and six-month study endpoints.
RESULTS: C-RPNI constructs remained viable over the study period with regeneration and revascularization evident on histologic analysis. At both three and six months, electrical stimulation of proximal peroneal nerve evoked efferent signals (CMAPs) and muscle contractions that were measured from the free muscle graft component of the C-RPNI. The average CMAP amplitude recorded from the muscle was 6.3 ± 1.4 mV at three months and 6.1 ± 1.6 mV at six months. The average conduction velocity was 11.0 ± 2.7 m/sec at three months and 12.0 ± 2.0m/sec at six
